Göran Tuvstedt

The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015.

Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca.

Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021.

Coresonic AB was formed as a result of a need to develop a new wireless baseband processor architecture that was programmable but did not suffer the usual downsides of increased power consumption and cost. They were founded in 2004 based on the outcome of a three-year research project at the research center Stringent at Linköping University, Sweden. The founders include Professor Dake Liu, Dr. Eric Tell, Dr. Anders Nilsson and Professor Christer Svensson from the electrical engineering department who bring together decades of experience from research, development and marketing of semiconductors and IP. Its patented architecture offers a solution to the key issues faced by developers of baseband products for the WiMAX and 4G market. They provide a semiconductor core design and support the core with protocol specific firmware solutions. These deliver the flexibility necessary to both stay on top of the changing standards, and to cope with the myriad combinations of standards whilst using the same architecture. The optimized design delivers significant gains in power efficiency and cost over traditional programmable or DSP based architectures that are needed to drive high volume solutions. The flexibility allows wireless chip designers to gain much earlier entry to the market, whilst saving on development resource by introducing a volume competitive architecture from day one.

RxEye AB sells cloud-based information technology services for remote viewing of medical images. It develops a web service for exchanging services and expertise between different hospitals and physicians. The company was founded by Sten Magnus Hök and Ulf Lars Harald Hertin in September 2010 and is headquartered in Stockholm, Sweden.

Advanced MR Analytics AB offers solutions for body composition analysis. It transforms subjective magnetic resonance images into fat and muscle measurements. The firm provides technical research such as data acquisition and reconstruction; registration and fusion; machine learning and signal representation; modelling and simulation; simulation, classification, and quantification; visualization and image enhancement; and user interfaces and interaction. The company was founded by David Magnus Borga and Olof Erik Gunnar Dahlqvist Leinhard in 2010 and is headquartered in Link?ping, Sweden.

Serendipity Partners Management AS (Serendipity Partners) is a private equity/venture capital firm founded in 2015 by Michael Bodd. The firm is headquartered in Oslo, Norway.

Part of Smartfish AS, Smartfish AB is a Swedish company that focuses on medical nutrition for cancer patients. The company is based in Solna, Sweden. The company believes that good nutritional status is crucial for successful treatment and optimal outcomes. Smartfish has a slim and flexible organizational structure and aims to grow through strategic relationships with leading R&D, production, and distribution partners. The company's medical nutrition products are used to improve the nutritional status of malnourished or undernourished patients.

Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway.

Mashmobile AB is an international software company operating in the field of fixed-mobile convergence. The firm is situated in Lund, Los Angels, Seoul, and represented in Tokyo. Mobile devices have so far remained peripheral on the web, glutted with clients to enable interaction with various websites and other applications. As the web goes mobile, it wants to enable mobile devices to speak the full language of the Internet. In short, the mobile device can now be address by its own unique URL, accessible via an ordinary web API. You will soon realize the advantages. Mashmobile entrenches the concept of mobility in the Internet world and offers vast opportunities to the mobile industry, pushing a new frontline of mobile service creation. Mashmobile was founded in the autumn of 2004 as a project together with Lund University and was incorporated in 2006.

Airsonett AB is a holding company that is engaged in the research and development of a non-pharmaceutical treatment for asthma. Its product Airsonett is based on temperature controlled Laminar Airflow technology that creates a radically reduced allergen exposure in the breathing zone for treatment of asthma, allergic rhinitis, and atopic eczema. The company was founded by Jan Tommy Lennart Hedberg, Jan Kristensson, and Dan Kristensson in 2000 and is headquartered in Ängelholm, Sweden.

Market Bridge Capital SAS provides investment advice. The private company is based in Paris, FR. and has subsidiaries in the United States. The French company was founded in 2010. Maya Dray has been the CEO of the company since 2010.

Anyfi Networks AB provides mobile Wi-Fi solutions. It offers technology that enables operators to provide a secure and automatic connection to the end customer's home network. The firm's products give mobile operators the opportunity to effectively and securely offload data traffic from mobile networks onto Wi-Fi networks. The company was founded in 2005 by Björn Olof Fuad Smedman, Karl Netzell and Johan Olof Almbladh and is headquartered in Malmo, Sweden.

Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden.

Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden.

Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.